Published in BJOG on January 01, 2005
Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis (2006) 2.05
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med (2010) 1.13
Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol (2006) 1.04
Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child (2006) 1.01
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes. Clin Microbiol Rev (2016) 0.94
A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One (2014) 0.84
Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children. BMC Pediatr (2005) 0.83
Seroprevalence and correlates of Toxoplasma gondii infection in Yoremes (Mayos) in Mexico: a cross-sectional study. BMJ Open (2016) 0.75
Nationwide registry-based ecological analysis of Q fever incidence and pregnancy outcome during an outbreak in the Netherlands. BMJ Open (2015) 0.75
Rate of congenital toxoplasmosis in large integrated health care setting, California, USA, 1998-2012. Emerg Infect Dis (2014) 0.75
Interaction between bedding and sleeping position in the sudden infant death syndrome: a population based case-control study. BMJ (1990) 7.42
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (1994) 4.78
Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet (2008) 3.65
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
"Clusters" of anophthalmia in Britain. BMJ (1993) 3.04
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev (2004) 2.83
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis (1996) 2.43
Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet (2008) 2.42
Food Poisoning Due to Toxic Substances Formed by Strains of the Cloacae-Aerogenes Group. Am J Public Health Nations Health (1932) 2.34
Streptococcal infection, Tourette syndrome, and OCD: is there a connection? Neurology (2009) 2.33
Malaria chemoprophylaxis: why mefloquine? Lancet (1990) 2.13
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev (2001) 2.08
NOTES ON THE CULTIVATION OF TREPONEMA PALLIDUM. J Exp Med (1915) 2.07
The Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N Engl J Med (1985) 2.04
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Approval of Laboratories for Surgical Pathology in New York State. Am J Public Health Nations Health (1934) 1.87
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
THE USE OF GLYCEROL AS A PRESERVATIVE FOR MILK SPECIMENS TO BE EXAMINED FOR HEMOLYTIC STREPTOCOCCI. Am J Public Health Nations Health (1933) 1.83
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol (1997) 1.67
Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976) (1997) 1.65
Changes in tidal volume, frequency, and ventilation induced by their measurement. J Appl Physiol (1972) 1.64
HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive. BMJ (2001) 1.62
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen (2005) 1.61
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
SIDS: risk reduction measures. Early Hum Dev (1994) 1.55
Has publication of the results of the ORACLE Children Study changed practice in the UK? BJOG (2010) 1.55
The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am Rev Respir Dis (1974) 1.55
Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol (1995) 1.54
In vivo gene electroinjection and expression in rat liver. FEBS Lett (1996) 1.53
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child (2006) 1.49
Vascular muscle cell depolarization and activation in renal arteries on elevation of transmural pressure. Am J Physiol (1987) 1.48
Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG (2003) 1.47
Dynamic sonography with provocation of pain for diagnosis of symptomatic mobile kidneys. Eur J Surg (2001) 1.46
Hydroxyl radical generation in oxygen-treated infants. Pediatrics (1997) 1.46
HIV and reproductive care--a review of current practice. BJOG (2006) 1.45
The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol (1978) 1.44
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol (2007) 1.44
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology (2010) 1.44
Quantitative bacterial examination of domestic water supplies in the Lesotho Highlands: water quality, sanitation, and village health. Bull World Health Organ (1999) 1.43
Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis? Hong Kong Med J (2010) 1.43
Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol (1996) 1.41
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther (2003) 1.41
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol (2010) 1.41
Preoperative ECMO in congenital cyanotic heart disease using the AREC system. Ann Thorac Surg (1997) 1.41
False-low carbon monoxide diffusing capacity measurement after general anesthesia. Chest (1996) 1.40
Bilateral papillitis in ocular toxoplasmosis. Eye (Lond) (2009) 1.39
View 1: Assisted conception in couples with HIV infection. Sex Transm Infect (2003) 1.38
Microalbuminuria in diabetes. Med J Aust (1994) 1.38
Type of delivery onset has a significant impact on post-natal mortality in preterm infants of less than 30 weeks' gestation. Acta Paediatr (2014) 1.38
Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol (2004) 1.37
Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg (1992) 1.29
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl (1992) 1.28
Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1991) 1.28
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun (1999) 1.26
Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther (1995) 1.24
The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants. J Cell Biol (1985) 1.23
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med (1984) 1.22
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J (1995) 1.21
Performance of European laboratories testing serum samples for Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1996) 1.20
Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs (2000) 1.19
Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen (2007) 1.18
Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization. Exp Clin Immunogenet (1985) 1.16
Chemical synthesis, cloning and expression in mammalian cells of a gene coding for human tissue-type plasminogen activator. Gene (1988) 1.16
Visual and somatosensory evoked cortical potentials in multiple sclerosis. J Neurol Neurosurg Psychiatry (1979) 1.16
Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol (1988) 1.14
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther (2000) 1.14
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy (2006) 1.12
Agglutination in the Diagnosis of Enteric Disease. Am J Public Health Nations Health (1933) 1.12
Recent trends in research on congenital toxoplasmosis. Int J Parasitol (2001) 1.10
Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect (2001) 1.10
Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS (1996) 1.10
Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis (1992) 1.10
Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J (2000) 1.09
Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol (1999) 1.09
Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci (1994) 1.09
A new europium chelate for protein labelling and time-resolved fluorometric applications. Clin Biochem (1988) 1.08
Studies on the effect of distamycin A on the DNA dependent RNA polymerase system. Biochem Biophys Res Commun (1971) 1.07
Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol (1996) 1.07
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther (2000) 1.06
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin Exp Immunol (1994) 1.06
Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur J Clin Microbiol Infect Dis (1996) 1.06
Toxopert-I: knowledge-based automatic interpretation of serological tests for toxoplasmosis. Comput Methods Programs Biomed (1997) 1.05